Form 4: Rockwell Medical SVP, Chief Commercial Officer Timothy Chole Sells Shares

Timothy Chole, SVP, Chief Commercial Officer of Rockwell Medical, sold 2,868 shares of common stock on April 1, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On April 1, 2025, Timothy Chole, the SVP, Chief Commercial Officer of Rockwell Medical, sold 2,868 shares of common stock.
• The sale was executed at a price of $1.08 per share.
• The transaction was conducted under a Rule 10b5-1 trading plan adopted on June 7, 2024.
• Following the transaction, Chole directly owns 46,035 shares of Rockwell Medical common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting a stock sale by an officer, which is neutral in sentiment. The use of a 10b5-1 plan mitigates potential negative interpretations.

Industry Context

Form 4 filings are a routine part of the regulatory landscape, providing transparency into the transactions of company insiders. The use of a 10b5-1 plan suggests the sale was pre-planned and not based on any specific non-public information at the time of the transaction.

Stakeholder Impact

• The stock sale by a company officer could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan may alleviate concerns.

Key Dates

Keywords

Rockwell Medical, RMTI, Timothy Chole, stock sale, Form 4, Rule 10b5-1, insider trading